Gene Nudelman: Can a Hemostatic Gauze Perform When Blood Clotting is Impaired?
Gene Nudelman, CEO at Core Scientific Creations Ltd, shared a post on LinkedIn:
“Can a hemostatic gauze perform when blood clotting is impaired?
Independent testing conducted at the University Hospital of Tübingen evaluated Wound Clot Advanced Bleeding Control in fresh human blood containing increasing concentrations of heparin.
The results demonstrated clot formation an000d coagulation activation in blood containing up to 3–4 IU/mL heparin, highlighting Wound Clot’s ability to support hemostasis under challenging anticoagulated conditions.
For trauma teams, surgeons, military medics, and emergency responders, every second matters – and so does confidence in the technology being used.
When clotting is compromised, performance matters.”
Stay updated with Hemostasis Today.
-
Jul 26, 2026, 01:48Rob Maloney: Why Global Diagnosis is the Missing Piece in Bleeding Disorder Care
-
Jul 26, 2026, 01:35Moustafa Abdou: Ehlers-Danlos Syndrome – Why Collagen Matters for Hemostasis
-
Jul 26, 2026, 01:25Vrisha Shah: Exploring Transgenic Mouse Models for Pregnancy Outcomes at ISTH 2026
-
Jul 26, 2026, 01:06Christine Bork: Why Misinformation Around a Single Vitamin Postpartum is Putting Babies at Risk
-
Jul 26, 2026, 00:44A Significant Step Forward For People With Bleeding Disorders In The Dominican Republic – WFH
-
Jul 25, 2026, 18:00The Evolving Landscape of Factor Replacement Therapy – EAHAD
-
Jul 25, 2026, 17:43Heghine Khachatryan: Advancing Care for Women and Girls With Hemophilia
-
Jul 25, 2026, 17:00Revathy R Menon: A Memorable Milestone at the 39th ISBT Congress
-
Jul 25, 2026, 16:19Nicola Potere: From Scientific Exchange to Global Collaboration at ISTH 2026